Delivery Order SPE2DB22D1017-SPE2DB23FF7FF
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $5,998.79 for the supply of 4,564,490,577 units of the pharmaceutical product Varenicline 1 mg Tablet 56s. The award was made by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $1,736.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of 56 tablets of the medication Varenicline 1 mg. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,490.37, is for the delivery of 4,562,987,018 units of the prescription medication Varenicline 1 mg tablet in 56-count packages. The contract has an ultimate completion date of December 5, 2023 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is a subsidiary of the parent...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,617.11 for the supply of 4560616529 - Varenicline 1 mg Tablets, 56 count. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and has an ultimate completion date of April 18, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,055.23, is for the delivery of Varenicline 1 mg tablets over a term ending on March 14, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a...
- This federal contract award is for the delivery of 4,560,941,279 units of Varenicline 1 mg Tablets in 56-count packages. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has a ceiling value of $2,858.47 and runs through May 16, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Varenicline 1 mg tablets in quantities of 56 per bottle. The contract has a ceiling value of $5,509.76 and is a firm fixed-price delivery order with a performance period ending on January 30, 2024. The contract was awarded on January 29, 2024 and was not set aside for any specific business type....
- This federal contract award, valued at $4,277.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the provision of 4,557,931,791 varenicline 1 mg tablets. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this firm fixed-price delivery order contract, which does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) with the delivery of varenicline 1 mg tablets in 56-count packages. The contract has a ceiling value of $15,444.78 and a period of performance through January 2, 2024. It is a firm-fixed-price delivery order contract, indicating a defined scope of supply at a predetermined price. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- This federal contract award is for the delivery of 56 tablets of the pharmaceutical product Varenicline 0.5 mg. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,590.08 and a completion date of January 26, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FF7FFDelivery Order
This federal contract award, identified as SPE2DB22D1017 and SPE2DB23FF7FF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,970,319 units of Varenicline 1 mg tablets in packages of 56. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,527.97 and an ultimate completion date of May 18, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 5/17/23 |